Cyclooxygenase-2 Inhibitors in Inflammation and Cancer (Q169000)

From geokb
Revision as of 14:40, 24 May 2024 by Sky (talk | contribs) (‎Created a new Item: Added new OpenAlex topic claimed by USGS staff from API)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
This cluster of papers focuses on the use of cyclooxygenase-2 (COX-2) inhibitors, such as rofecoxib, celecoxib, and naproxen, in the context of inflammation and cancer
  • Cyclooxygenase-2 Inhibitors
  • Inflammation
  • Cancer
  • Prostaglandins
  • NSAIDs
  • Cardiovascular Risk
  • Colorectal Cancer
  • Chemoprevention
  • Prostaglandin E2
  • COX-2
Language Label Description Also known as
English
Cyclooxygenase-2 Inhibitors in Inflammation and Cancer
This cluster of papers focuses on the use of cyclooxygenase-2 (COX-2) inhibitors, such as rofecoxib, celecoxib, and naproxen, in the context of inflammation and cancer
  • Cyclooxygenase-2 Inhibitors
  • Inflammation
  • Cancer
  • Prostaglandins
  • NSAIDs
  • Cardiovascular Risk
  • Colorectal Cancer
  • Chemoprevention
  • Prostaglandin E2
  • COX-2

Statements